Results 171 to 180 of about 76,100 (290)

Pre-Emptive Targeting of the Epitope Spreading Cascade with Genetically Modified Regulatory T Cells During Autoimmune Demyelinating Disease [PDF]

, 2001
Ling Yin, Canqing Yu, Andrea E. Edling, Julie A. Kawczak, Peter M. Mathisen, Tania Nanavati, Justin M. Johnson, Vincent K. Tuohy   +7 more
openalex   +1 more source

Epidemiology, Presentation, Management and Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy in Birmingham, UK: The Impact of Ethnicity

Journal of the Peripheral Nervous System, Volume 30, Issue 4, December 2025.
ABSTRACT Background Whether ethnicity impacts on epidemiology, presentation, management, and outcome is unknown in chronic inflammatory demyelinating polyneuropathy (CIDP). Methods We studied the prevalence/incidence of CIDP in Asian (Indian/Pakistani/Bangladeshi) and white subjects in Birmingham, UK, and associations of ethnicity with demographics ...
Zeinab Rajabally, Lydia Spencer, Niraj Mistry, Yusuf A. Rajabally   +3 more
wiley   +1 more source

Short-term safety of inactivated SARS-Cov-2 vaccines in Chinese patients with central nervous system inflammatory demyelinating diseases. [PDF]

Vaccine X, 2023
Zhao D, Zhang W, Ma X, Zhao R, Yao L, Lu J, Yan X, Bai M, Zhang G, Li H, Guo J.   +10 more
europepmc   +1 more source

Gene microarrays and experimental demyelinating disease: a tool to enhance serendipity [PDF]

, 2001
Lawrence Steinman
openalex   +1 more source

Insight in the Unmet Needs Encountered During the Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Journal of the Peripheral Nervous System, Volume 30, Issue 4, December 2025.
ABSTRACT Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare acquired immune‐mediated disorder affecting peripheral nerves, manifesting most commonly as symmetric, proximal, and distal weakness with sensory loss. Although the 2021 European Academy of Neurology/Peripheral Nerve Society guidelines provide evidence‐based and ...
Jeffrey A. Allen, Helmar C. Lehmann, Eduardo Nobile‐Orazio, Luis Querol, Yusuf A. Rajabally   +4 more
wiley   +1 more source

Genetic Basis of Inflammatory Demyelinating Diseases of the Central Nervous System: Multiple Sclerosis and Neuromyelitis Optica Spectrum. [PDF]

Genes (Basel), 2023
Ortiz GG, Torres-Mendoza BMG, Ramírez-Jirano J, Marquez-Pedroza J, Hernández-Cruz JJ, Mireles-Ramirez MA, Torres-Sánchez ED.   +6 more
europepmc   +1 more source

Peptidylarginine deiminase: a candidate factor in demyelinating disease [PDF]

, 2002
M.A. Moscarello, Laura B. Pritzker, Fabrizio G. Mastronardi, D. D. Wood   +3 more
openalex   +1 more source

Wearable Monitoring Captures Sleep Disturbances in Patients With Chronic Inflammatory Demyelinating Polyneuropathy

Journal of the Peripheral Nervous System, Volume 30, Issue 4, December 2025.
ABSTRACT Background and Aims Previous studies suggest that patients with chronic inflammatory demyelinating polyneuropathy (CIDP) experience impaired sleep, contributing to fatigue. Traditional methods like polysomnography or questionnaires are resource‐intensive and may not capture sleep in natural settings.
Jan Voth, Charlotte von Gall, Noëmi Gmahl, Noah M. Werner, Gerd Meyer zu Hörste, Sven G. Meuth, Marc Pawlitzki, Lars Masanneck   +7 more
wiley   +1 more source

Anti-IL-6 therapies in central nervous system inflammatory demyelinating diseases. [PDF]

Front Immunol, 2022
Jiao L, Guo S.
europepmc   +1 more source

TNFα: kill or cure for demyelinating disease? [PDF]

, 2002
Bente Finsen, Jack P. Antel, Trevor Owens   +2 more
openalex   +1 more source